Matrix metalloproteinase-3 is a potent prognostic factor associated with cell proliferation and migration in prostate cancer
Prostate cancer is a common malignancy in men around the world, and it is crucial to explore novel biomarkers to improve its treatment. Prostate cancer cells typically invade the surrounding stroma, and remodeling of the extracellular matrix (ECM) is a crucial step in the progress of prostate cancer...
Saved in:
Main Authors: | Ai Sato, Kiyoshi Takagi, Mio Yamaguchi-Tanaka, Jotaro Okushima, Yuto Yamazaki, Akihiro Ito, Takashi Suzuki |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Experimental and Molecular Pathology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0014480025000036 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TGF-β induces cholesterol accumulation to regulate the secretion of tumor-derived extracellular vesicles
by: Dorival Mendes Rodrigues-Junior, et al.
Published: (2025-02-01) -
Collagen turnover biomarkers to predict outcome of patients with biliary cancer
by: Leonard Kaps, et al.
Published: (2025-02-01) -
RETRACTED ARTICLE: Combined treatment of glibenclamide and CoCl2 decreases MMP9 expression and inhibits growth in highly metastatic breast cancer
by: Zhe Rong, et al.
Published: (2013-05-01) -
Discoidin domain receptors; an ancient family of collagen receptors has major roles in bone development, regeneration and metabolism
by: Renny T. Franceschi, et al.
Published: (2023-05-01) -
Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease
by: Qingrui Duan, et al.
Published: (2025-02-01)